• Publications
  • Influence
Circulating miR-181a as a Potential Novel Biomarker for Diagnosis of Acute Myocardial Infarction
Background: In this study, we tested the hypothesis that miR-181a levels increase during acute myocardial infarction. We investigated circulating miR-181a as a potential novel biomarker for earlyExpand
  • 29
  • 3
Scientific research progress of COVID‐19/SARS‐CoV‐2 in the first five months
  • H. Li, Z. Liu, J. Ge
  • Medicine
  • Journal of cellular and molecular medicine
  • 22 April 2020
A cluster of pneumonia (COVID‐19) cases have been found in Wuhan China in late December, 2019, and subsequently, a novel coronavirus with a positive stranded RNA was identified to be the aetiologicalExpand
  • 24
  • 2
Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes.
Importance Additional treatments are needed for heart failure with reduced ejection fraction (HFrEF). Sodium-glucose cotransporter 2 (SGLT2) inhibitors may be an effective treatment for patients withExpand
  • 48
  • 1
M2 macrophage-derived exosomes carry microRNA-148a to alleviate myocardial ischemia/reperfusion injury via inhibiting TXNIP and the TLR4/NF-κB/NLRP3 inflammasome signaling pathway.
  • Y. Dai, S. Wang, +6 authors J. Ge
  • Medicine
  • Journal of molecular and cellular cardiology
  • 19 February 2020
BACKGROUND Reperfusion may cause injuries to the myocardium in ischemia situation. Emerging studies suggest that exosomes may serve as key mediators in myocardial ischemia/reperfusion (MI/R) injury.Expand
  • 11
  • 1
Smartphone and social media-based cardiac rehabilitation and secondary prevention in China (SMART-CR/SP): a parallel-group, single-blind, randomised controlled trial.
BACKGROUND Coronary heart disease is rapidly increasing in developing countries, but access to cardiac rehabilitation and secondary prevention remains low. In this study, we aimed to assess theExpand
  • 7
  • 1
Drug-Coated Balloons for Coronary Artery Disease: Third Report of the International DCB Consensus Group.
Although drug-eluting stents are still the default interventional treatment of coronary artery disease, drug-coated balloons (DCBs) represent a novel alternative therapeutic strategy in certainExpand
  • 8
Post-Hoc Study: Intravenous Hydration Treatment in Chinese Patients with High Risk of Contrast-Induced Nephropathy Following Percutaneous Coronary Intervention
Contrast-induced nephropathy (CIN) develops after the injection of iodinated contrast media. This is a post hoc analysis of the data obtained from the TRUST study, which was a prospective,Expand
  • 9
Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus-eluting stents.
OBJECTIVE To investigate the impact of ischemic and bleeding risk factors on long-term clinical outcomes of patients with diabetes mellitus (DM) undergoing percutaneous coronary intervention (PCI)Expand
  • 1
Size-fractionated particulate air pollution and myocardial infarction emergency hospitalization in Shanghai, China.
  • J. Hu, M. Tang, +6 authors J. Ge
  • Medicine
  • The Science of the total environment
  • 1 October 2020
BACKGROUND Fine particulate matter (PM2.5) air pollution has been associated with increased risks of acute myocardial infarction (AMI), but it remains unknown about the potentially differentiatedExpand
  • 2